Journal
PHARMACEUTICS
Volume 11, Issue 7, Pages -Publisher
MDPI
DOI: 10.3390/pharmaceutics11070308
Keywords
curcumin; dissolving microneedles; intradermal; poly(vinylalcohol); nanosuspension
Categories
Funding
- Wellcome trust [WT094085MA]
Ask authors/readers for more resources
The objective of this study was to evaluate the intradermal delivery of curcumin utilising poly(vinylalcohol) (PVA)-based microneedles loaded with curcumin nanosuspension (CU-NS). Nanoprecipitation was used to formulate the CU-NS which was then incorporated into PVA microneedles arrays consisting of 11 x 11 microneedles of conical shape, measuring 900 mu m in height and with 300 mu m base diameter. The nanosuspension particle size was 520 +/- 40 nm, with a polydispersity of 0.27 +/- 0.02 using sodium lauryl sulfate (SLS) as a stabiliser. In vitro dissolution studies in 10% w/v Tween 80 showed that the CU-NS dissolved significantly faster than unmodified curcumin powder, with 34% released from the CU-NS, compared to 16% from the curcumin powder after 48 h. The CU-NS-loaded microneedles (CU-MN) were able to withstand a compression force of 32 N for 30 s. Moreover, these microneedles were able to penetrate excised neonatal porcine skin to a depth of 500 mu m, dissolved completely in the skin within 60 min. After CU-MN dissolution, the drug diffused from the application site and migrated through the skin layers down to 2300 mu m, significantly more than observed with topical application of CU-NS. This suggest that the fabricated microneedles with the incorporated CU-NS could enhance the intradermal delivery of curcumin.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available